MCA registered Company Details
InsightsCompaniesSectorsDirectorsInvestorsCompare
RegisterKaro › MCA registered Company Details

Biotrance

U24232DL2011PTC217363ActivePrivateUnlisted
Last updated: 2026-06-09
30
Compliance Health · F
3 / 9 signals passed

Biotrance is a Private Indian company incorporated in 2011 and based in Delhi, India. Biotrance operates in Pharmaceuticals & Chemicals (NIC 24232) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.

Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7Health F · 30/100
Revenue (latest FY)
—
Awaiting extraction
PAT (latest FY)
—
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
—
—
Filings on Record
0
All current
Incorporated
2011
15 years old
State
Delhi
Sector
Pharmaceuticals & Chemicals
NIC 24232
Class
Private
Sub-category
—
Authorized Capital
—
Paid-up Capital
—
Members
—
Last AGM
—
Last Balance Sheet
—
Latest Filing
—
Registered Email
—
Registered Office
—
BiotranceTRACXN · PUBLIC DATA
Brand Biotrance · Legal entity Biotrance

Biotrance - Offers proteomics solutions.

Total Funding
Latest Round
—
Revenue
Valuation
Funding Rounds
—
Employees
—
Stage
Unfunded
HQ
Delhi
Founded
2011
Source: Tracxn (public profile) · joined to MCA on CIN U24232DL2011PTC217363

Quick facts

Identity · Activity · Auditor · Contact
Registered office
—
NIC code
24232
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
—
Section
Pharmaceuticals & Chemicals
ROC
—
Website
https://biotrance.com
Class · sub-category
Private
Incorporation · Last AGM
— · —

Directors

From MGT-7 annual returnLocked
SI
Suresh Iyer
Managing Director
3.8y · Pune · DIN 7405393
DR
Deepa Reddy
Whole-time Director
8.2y · New Delhi · DIN 3669725
PN
Priya Nair
Additional Director
5.6y · Ahmedabad · DIN 3608485
Get the full board of directors

Directors, DINs & appointment history for Biotrance.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

MCA Filings

AOC-4 · MGT-7 historyLocked
FormFYFiledDueDelayStatus
AOC-4FY2024-2530 Oct 202430 Oct 20240dfiled
MGT-7FY2024-2524 Nov 202429 Nov 20240dfiled
AOC-4FY2023-2430 Oct 202330 Oct 20230dfiled
MGT-7FY2023-2424 Nov 202329 Nov 20230dfiled
AOC-4FY2022-2330 Oct 202230 Oct 2022+24dfiled
MGT-7FY2022-2320 Nov 202229 Nov 20220dfiled
Get financial statements & other filing documents

Full MCA filing history for Biotrance.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked
Charge IDHolderAmountCreatedStatus
203680914ICICI Bank Ltd(Bank)₹1.25 Cr04 Jul 2023Open
941235551HDFC Bank Ltd(Bank)₹19.87 Cr27 Jan 2022Satisfied
609886419HDFC Bank Ltd(Bank)₹9.38 Cr19 Sep 2021Open
444514587Axis Bank Ltd(Bank)₹24.44 Cr04 Jul 2019Satisfied
548877443HDFC Bank Ltd(Bank)₹7.39 Cr12 Mar 2021Open
598225786Kotak Mahindra Bank Ltd(Bank)₹16.81 Cr19 Sep 2023Open
See registered charges & lenders

Charge IDs, lenders & amounts for Biotrance.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Financial Performance

Revenue · PAT · Net worth by FYLocked
FYRevenuePATNet WorthTotal AssetsEmployees
FY2024-25₹25.11 Cr₹2.21 Cr₹14.53 Cr₹32.17 Cr364
FY2023-24₹21.02 Cr₹2.03 Cr₹12.15 Cr₹31.24 Cr308
FY2022-23₹20.91 Cr₹2.39 Cr₹22.29 Cr₹32.59 Cr253
FY2021-22₹11.97 Cr₹1.22 Cr₹6.50 Cr₹20.11 Cr100
Gain deeper financial insights of this entity

Audited financials & ratios for Biotrance.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Detailed Financials

Income statement + balance sheetLocked
Line itemFY2024-25FY2023-24FY2022-23FY2021-22
Income statement
Revenue from operations₹25.11 Cr₹21.02 Cr₹20.91 Cr₹11.97 Cr
Other income₹54.21 L₹21.53 L₹23.13 L₹37.51 L
Total income₹25.65 Cr₹21.23 Cr₹21.14 Cr₹12.35 Cr
Total expenses₹22.82 Cr₹18.64 Cr₹18.09 Cr₹10.78 Cr
Profit before tax₹2.88 Cr₹2.64 Cr₹3.10 Cr₹1.59 Cr
Profit / (Loss) after tax₹2.21 Cr₹2.03 Cr₹2.39 Cr₹1.22 Cr
Balance sheet
Equity / Net worth₹14.53 Cr₹12.15 Cr₹22.29 Cr₹6.50 Cr
Borrowings₹7.55 Cr₹8.62 Cr₹3.22 Cr₹7.23 Cr
Current liabilities₹7.71 Cr₹6.69 Cr₹4.29 Cr₹4.74 Cr
Total liabilities₹17.64 Cr₹19.09 Cr₹10.30 Cr₹13.61 Cr
Current assets₹14.52 Cr₹12.22 Cr₹11.52 Cr₹8.43 Cr
Cash & equivalents₹4.79 Cr₹1.55 Cr₹2.03 Cr₹1.65 Cr
Total assets₹32.17 Cr₹31.24 Cr₹32.59 Cr₹20.11 Cr
Employees364308253100
Gain deeper financial insights of this entity

Audited financials & ratios for Biotrance.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Compounded Annual Growth Rate

Derived from multi-FY filingsLocked
MetricLatest value1Y CAGR3Y CAGR5Y CAGR
Revenue₹25.11 Cr+28.9%+21.0%+17.5%
Profit after Tax₹2.21 Cr-2.5%+21.3%+14.3%
Net Worth₹14.53 Cr+23.0%+3.4%+5.4%
Employees364+22.2%+1.7%-0.9%
Gain deeper financial insights of this entity

Audited financials & ratios for Biotrance.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Financial Ratios

Profitability · leverage · efficiencyLocked
FYRevenuePATPAT marginRev growthROEROAD/ERev/emp
FY2024-25₹25.11 Cr₹2.21 Cr+8.81%+6.48%+15.22%+6.87%0.52₹6.90 L
FY2023-24₹21.02 Cr₹2.03 Cr+9.65%+1.19%+16.70%+6.49%0.71₹6.82 L
FY2022-23₹20.91 Cr₹2.39 Cr+11.41%+32.85%+10.70%+7.32%0.14₹8.27 L
FY2021-22₹11.97 Cr₹1.22 Cr+10.20%+20.67%+18.79%+6.07%1.11₹11.97 L
Gain deeper financial insights of this entity

Audited financials & ratios for Biotrance.

₹999₹249(excl. taxes)
Buy Financial Report
What you'll get
  • Financial Summary & Charts
  • Income Statement, Balance Sheet, Cashflow
  • Profitability, Liquidity & Growth Ratios
  • Audited Financial Statement (AOC-4)

Cap Table & Shareholding

Promoter · institutional · publicLocked
CategoryShareholdersShares held%
Promoters21,75,10,75176.49%
Institutional Investors310,21,1894.46%
Public & Others3743,61,32019.05%
See the full shareholding pattern

Promoter, institutional & public holding for Biotrance.

₹499₹169(excl. taxes)
Buy Financial & Company Filings
What you'll get
  • Incorporation Documents
  • Change in Directors & Designated Partner
  • Board Resolutions
  • Financial Statements & Annual Filings
  • Charge Documents (Summary)

Peer Benchmark

69 peersSame sector + state + ±5y vintage
MetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
—
PAT (latest FY)
—
Employees
—
—
—
—
Paid-up capital
—
Compliance Health
63
96
96
Bottom quartile · P1

Top 10 in Pharmaceuticals & Chemicals

by healthView all ›
01
Paid-up
Revenue
A · 96
02
Paid-up
Revenue
A · 96
03
Paid-up
Revenue
A · 96
04
Paid-up
Revenue
A · 96
05
S B Organics Ltd
Telangana · Inc 1988
Paid-up
Revenue
A · 96
06
Ecmas Resins PVT Ltd
Telangana · Inc 1987
Paid-up
Revenue
A · 96
07
Srinivasa Cystine Private Ltd
Telangana · Inc 1983
Paid-up
Revenue
A · 96
08
Paid-up
Revenue
A · 96
09
Paid-up
Revenue
A · 96
10
Paid-up
Revenue
A · 96

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned
GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned
MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned
AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned
CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned
IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned
IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned
eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Biotrance

When was Biotrance incorporated?
Biotrance was incorporated in 2011. Its CIN is U24232DL2011PTC217363 and it is registered with the relevant Registrar of Companies.
Where is Biotrance located?
Biotrance is headquartered in Delhi.
What sector does Biotrance operate in?
Biotrance operates in the Pharmaceuticals & Chemicals sector (NIC code 24232), classified as Indian Non-Govt Company.
Who are the directors of Biotrance?
Director details for Biotrance have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Biotrance?
Biotrance has authorized capital of — and paid-up capital of —.
Does Biotrance have any open charges?
Biotrance has no open MCA-registered charges on record.
What is Biotrance's Compliance Health Score?
RegisterKaro's Compliance Health Score for Biotrance is 30/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 3 of 9 signals passed.